Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice
- PMID: 3905609
- PMCID: PMC261128
- DOI: 10.1128/iai.50.3.655-659.1985
Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice
Abstract
Candida albicans has been shown to stimulate infection in mice by a number of bacteria when both organisms are inoculated intraperitoneally (E. Carlson, Infect. Immun. 39:193-197, 1983). When subcutaneous and intraperitoneal inoculations were given with Staphylococcus aureus and C. albicans injected at opposite sites, mixed infection was established at the site of fungal inoculation but not at the site of the bacterial injection. Histopathologic evaluation of tissues for the presence of C. albicans and S. aureus after intraperitoneal inoculation of both showed fungal growth in the mesentery and omentum of the abdominal cavity. Cocci were numerous and always associated with the fungi, located within the fungal growth rather than at its periphery. It was concluded that this growth pattern in some way protected the bacteria and was the basis for the generalized fungal stimulation of the bacterial infections observed. In addition to C. albicans, Candida stellatoidea, Candida tropicalis, Candida parapsilosis, Torulopsis glabrata, and heat-inactivated C. albicans also demonstrated some ability to protect bacteria injected simultaneously, although C. parapsilosis and T. glabrata were less effective than the other yeasts in this respect.
Similar articles
-
Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections.mBio. 2018 Jan 16;9(1):e01472-17. doi: 10.1128/mBio.01472-17. mBio. 2018. PMID: 29339423 Free PMC article.
-
Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice.Infect Immun. 1983 Jan;39(1):193-7. doi: 10.1128/iai.39.1.193-197.1983. Infect Immun. 1983. PMID: 6401691 Free PMC article.
-
Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus.Infect Immun. 2015 Oct 19;84(1):90-8. doi: 10.1128/IAI.01059-15. Print 2016 Jan. Infect Immun. 2015. PMID: 26483410 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.J Hosp Infect. 2002 Apr;50(4):243-60. doi: 10.1053/jhin.2001.1151. J Hosp Infect. 2002. PMID: 12014897 Review.
Cited by
-
Inhibition of polymicrobial biofilm formation by saw palmetto oil, lauric acid and myristic acid.Microb Biotechnol. 2022 Feb;15(2):590-602. doi: 10.1111/1751-7915.13864. Epub 2021 Jun 22. Microb Biotechnol. 2022. PMID: 34156757 Free PMC article.
-
Dysbiotic infection in the stomach.World J Gastroenterol. 2015 Oct 28;21(40):11450-7. doi: 10.3748/wjg.v21.i40.11450. World J Gastroenterol. 2015. PMID: 26523109 Free PMC article. Review.
-
Fluconazole prophylaxis is associated with a decreased rate of coagulase-negative Staphylococcal infections in a subset of extremely low birth weight neonates.Med Microbiol Immunol. 2014 Aug;203(4):251-6. doi: 10.1007/s00430-014-0337-2. Epub 2014 Apr 11. Med Microbiol Immunol. 2014. PMID: 24723053
-
Candida albicans mucin Msb2 is a broad-range protectant against antimicrobial peptides.Antimicrob Agents Chemother. 2013 Aug;57(8):3917-22. doi: 10.1128/AAC.00862-13. Epub 2013 Jun 3. Antimicrob Agents Chemother. 2013. PMID: 23733470 Free PMC article.
-
Biofilm extracellular DNA enhances mixed species biofilms of Staphylococcus epidermidis and Candida albicans.BMC Microbiol. 2013 Nov 14;13:257. doi: 10.1186/1471-2180-13-257. BMC Microbiol. 2013. PMID: 24228850 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical